Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 12/2017

Open Access 01-12-2017 | Retinal Disorders

Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser

Authors: Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Andrzej Grzybowski

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 12/2017

Login to get access

Abstract

Background

Chronic central serous chorioretinopathy is a serious therapeutic problem as it may lead to significant visual impairment. The aim of this retrospective study is to evaluate functional and morphological effects, as well as factors influencing visual outcome in patients treated by subthreshold micropulse laser.

Methods

Fifty-one eyes with chronic central serous chorioretinopathy lasting longer than 4 months (18 months on average) underwent up to two sessions of subtreshold micropulse laser treatment. Change in best corrected visual acuity, central retinal thickness, central retinal volume, average central retinal thickness and maximum subretinal fluid height were measured. Relation between the effects of the treatment and the initial retinal morphological and functional parameters was then analyzed.

Results

The total resorption of subretinal fluid was achieved in 36 cases (70.6%). There was, however, only a minor improvement in best corrected visual acuity of approximately one line on the Snellen chart. No correlation was observed between the effects of the treatment and the duration of the symptoms, retinal morphology and initial visual acuity. Younger patients responded better to the therapy.

Conclusion

Subthreshold micropulse laser treatment in chronic serous chorioretinopathy provides good morphological results, however significant improvement of visual acuity is not to be expected.
Literature
1.
Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR et al (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103:2070–2079CrossRefPubMed
2.
Gemenetzi M, De Salvo G, Lotery AJ (2010) Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye 24:1743–1756CrossRefPubMed
3.
Daruich A, Matet A, Dirani A, Bousquet E, Zho M, Farman N et al (2015) Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Progress in Retinal and Eye Research 48:82–118CrossRefPubMed
4.
Pare JR, Guo Y, Schechter-Perkins EM (2014) The evaluation of acute vision loss: central serous chorioretinopathy. Am J Emerg Med 32:396.e3–396.e4CrossRef
5.
Liew G, Quin G, Gillies M, Fraser-Bell S (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 41:201–214CrossRefPubMed
6.
Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P (2015) Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev 22:CD011841
7.
Wong KH, Lau KP, Chhablani J, Tao Y, Li Q, Wong IY (2016) Central serous chorioretinopathy: what we have learnt so far. Acta Ophthalmol 94:321–325CrossRefPubMed
8.
Liu B, Deng T, Zhang J (2016) Risk factors for central serous chorioretinopathy: A Systematic Review and Meta-Analysis. Retina 36:9–19CrossRefPubMed
9.
Lahousen T, Painold A, Luxenberger W, Schienle A, Kapfhammer HP, Ille R (2016) Psychological factors associated with acute and chronic central serous chorioretinopathy. Nord J Psychiatry 70:24–30CrossRefPubMed
10.
Khosla PK, Rana SS, Tewari HK, Azad RU, Talwar D (1997) Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers 28:693–697PubMed
11.
Gass JDM (1987) Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, 3rd edn. Mosby, St. Louis, pp 46–59
12.
Shulman S, Goldenberg D, Schwartz R, Habot-Wilner Z, Barak A, Ehrlich N et al (2016) Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 254:15–22CrossRefPubMed
13.
Pouw AE, Olmos de Koo LC (2015) Oral rifampin for central serous retinopathy: a strategic approach in three patients. Ophthalmic Surg Lasers Imaging Retina 46:98–102CrossRefPubMed
14.
Caccavale A, Romanazzi F, Imparato M, Negri A, Morano A, Ferentini F (2010) Low-dose aspirin as treatment for central serous chorioretinopathy. Clin Ophthalmol 4:899–903CrossRefPubMedPubMedCentral
15.
Caccavale A, Imparato M, Romanazzi F, Negri A, Porta A, Ferentini F (2009) A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy. Med Hypotheses 73:435–437CrossRefPubMed
16.
Chong CF, Yang D, Pham TQ, Liu H (2012) A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy. BMJ Case Rep. 2012 pii: bcr2012006970
17.
Salz DA, Pitcher JD III, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ (2015) Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina 46:439–444CrossRefPubMed
18.
Daruich A, Matet A, Dirani A, Gallice M, Nicholson L, Sivaprasad S, Behar-Cohen F (2016) Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy. Transl Vis Sci Technol 4(5):2CrossRef
19.
Kapoor KG, Wagner AL (2016) Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy: A Comparative Analysis. Ophthalmic Res 56:17–22CrossRefPubMed
20.
Kretz FT, Beger I, Koch F, Nowomiejska K, Auffarth GU, Koss MJ (2015) Randomized Clinical Trial to Compare Micropulse Photocoagulation Versus Half-dose Verteporfin Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 46:837–843CrossRefPubMed
21.
Breukink MB, Mohr JK, Ossewaarde-van Norel A, den Hollander AI, Keunen JE, Hoyng CB et al (2016) Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Acta Ophthalmol 94:187–197CrossRefPubMed
22.
Alkin Z, Perente I, Ozkaya A, Alp D, Agca A, Aygit ED, Korkmaz S, Yazici AT, Demirok A (2014) Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Clin Ophthalmol 8:685–690CrossRefPubMedPubMedCentral
23.
Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF (2014) Macula Society CSC Collaborative Study Group. Research and Education Committee and Website Committee. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 121:1073–1078PubMed
24.
Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ et al (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288–298CrossRefPubMed
25.
Russo A, Turano R, Morescalchi F, Gambicorti E, Cancarini A, Duse S, Costagliola C, Semeraro F (2017) Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 255:1141–1148CrossRefPubMed
26.
Lim JW, Ryu SJ, Shin MC (2010) The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy. Korean J Ophthalmol 24:155–158CrossRefPubMedPubMedCentral
27.
Ünlü C, Erdogan G, Aydogan T, Sezgin Akcay BI, Kardes E, Kiray GA, Bozkurt TK (2016) Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy. J Ophthalmic Vis Res 11:61–65CrossRefPubMedPubMedCentral
28.
Altun A, Kurna SA, Olcaysu OO, Sengor T, Aki SF, Atakan TG (2014) Success of ranibizumab in central serous chorioretinopathy resistant to bevacizumab. J Ocul Pharmacol Ther 30:842–846CrossRefPubMed
29.
Park SU, Lee SJ, Kim M (2014) Intravitreal anti-vascular endothelial growth factor versus observation in acute central serous chorioretinopathy: one-year results. Korean J Ophthalmol 28:306–313CrossRefPubMedPubMedCentral
30.
Koss MJ, Beger I, Koch FH (2012) Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye 26:307–314CrossRefPubMed
31.
Bae SH, Heo J, Kim C, Kim TW, Shin JY, Lee JY et al (2014) Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial. Ophthalmology 121:558–565CrossRefPubMed
32.
Barnstable CJ, Tombran-Tink J (2004) Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog Ret Eye Res 23:561–577CrossRef
33.
Glaser BM, Campochiaro PA, Davis JL et al (1987) Retinal pigment epithelial cells release inhibitors of neovascularization. Ophthalmology 94:780–784CrossRefPubMed
34.
Pollack JS, Kim JE, Pulido JS, Burke JM (1998) Tissue effects of subclinical diode laser treatment of the retina. Arch Ophthalmol 116:1633–1639CrossRefPubMed
35.
Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC (2012) Long-term safety,high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina 32:375–386CrossRefPubMed
36.
Brader HS, Young LH (2016) Subthreshold Diode Micropulse Laser: A Review. Semin Ophthalmol 31:30–39CrossRefPubMed
37.
Luttrull JK, Chang DB, Margolis BW, Dorin G, Luttrull DK (2015) Laser resensitization of medically unresponsive neovascular age-related macular degeneration : Efficacy and implications. Retina 35:1184–1194CrossRefPubMed
38.
Luttrull JK, Musch DC, Mainster MA (2005) Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 89:74–80CrossRefPubMedPubMedCentral
39.
Vujosevic S, Martini F, Convento E, Longhin E, Kotsafti O, Parrozzani R et al (2013) Subthreshold laser therapy for diabetic macular edema: metabolic and safety issues. Curr Med Chem 20:3267–3271CrossRefPubMed
40.
Vujosevic S, Martini F, Longhin E, Convento E, Cavarzeran F, Midena E (2015) Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema: Morphologic and Functional Safety. Retina 35:1594–1603CrossRefPubMed
41.
Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E (2010) Microperimetry and fundus autofluorescence in diabetic macular edema:subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30:908–916CrossRefPubMed
42.
Luttrull JK (2015) Low-intensity/high-density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina 36:1658–1663CrossRef
43.
44.
Scholz P, Ersoy L, Boon CJ, Fauser S (2015) Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy. Ophthalmologica 234:189–194CrossRefPubMed
45.
Yadav NK, Jayadev C, Mohan A, Vijayan P, Battu R, Dabir S et al (2015) Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye 29:258–264CrossRefPubMedPubMedCentral
46.
Kim JY, Park HS, Kim SY (2015) Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 253:2129–2135CrossRefPubMed
47.
Malik KJ, Sampat KM, Mansouri A, Steiner JN, Glaser BM (2015) Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy. Retina 35:532–536CrossRefPubMed
48.
Özmert E, Demirel S, Yanık Ö, Batıoğlu F (2016) Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy. J Ophthalmol 2016:3513794PubMedPubMedCentral
49.
Scholz P, Altay L, Fauser S (2016) Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy. Eye 30:1371–1377CrossRefPubMedPubMedCentral
50.
Brinkmann R, Schüle G, Neumann J, Framme C, Pörksen E, Elsner H, Theisen-Kunde D, Roider J, Birngruber R (2006) Selective retina therapy: methods, technique, and online dosimetry. Ophthalmologe. 103:839–849CrossRefPubMed
51.
Elsner H, Pörksen E, Klatt C, Bunse A, Theisen-Kunde D, Brinkmann R, Birngruber R, Laqua H, Roider J (2006) Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 244:1638–1645CrossRefPubMed
52.
Framme C, Walter A, Berger L, Prahs P, Alt C, Theisen-Kunde D, Kowal J, Brinkmann R (2015) Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy. Ophthalmologica 234:177–188CrossRefPubMed
53.
Park YG, Kang S, Kim M, Yoo N, Roh YJ (2017) Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients. Graefes Arch Clin Exp Ophthalmol 255:1375–1383CrossRefPubMed
Metadata
Title
Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
Authors
Maciej Gawęcki
Agnieszka Jaszczuk-Maciejewska
Anna Jurska-Jaśko
Andrzej Grzybowski
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 12/2017
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3783-x

Other articles of this Issue 12/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2017 Go to the issue

Cornea

Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy

Refractive Surgery

Comparison of outcomes of scleral fixation with and without pars plana vitrectomy for the treatment of dislocated intraocular lens

Pediatrics

Stereopsis and fusion in anisometropia according to the presence of amblyopia

Pediatrics

Developmental visual deprivation: long term effects on human cone driven retinal function

Retinal Disorders

The relation of somatotypes and stress response to central serous chorioretinopathy

Oculoplastics and Orbit

Bell’s phenomenon in thyroid-associated inferior rectus myopathy